US 7655621
Cross-linked glycopeptide-cephalosporin antibiotics
granted A61KA61K31/545A61K38/00
Quick answer
US patent 7655621 (Cross-linked glycopeptide-cephalosporin antibiotics) held by Theravance, Inc. expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/545, A61K38/00, A61P, A61P31/00